Clinical Endoscopy

The Korean Society of Gastrointestinal Endoscopy (대한소화기내시경학회)
권호 표지
DOI QR코드

DOI QR Code

Experimental Gastric Non-Balloon Devices

  • Choi, Youn I (Division of Gastroenterology, Department of Internal Medicine, Gachon University, Gil Medical Center) ;
  • Kim, Kyoung Oh (Division of Gastroenterology, Department of Internal Medicine, Gachon University, Gil Medical Center)
  • Received : 2018.08.31
  • Accepted : 2018.09.19
  • Published : 2018.09.30
⟨ Previous Next ⟩

Abstract

Endoscopic bariatric therapies (EBTs) are promising alternatives to the conventional surgeries used to treat obesity and related metabolic conditions, targeting gastrointestinal anatomical and physiological processes. Many EBTs are at various stages of development and are aimed at promoting an early sense of satiety via anatomical and physiological mechanisms. In the present study, we focused on relevant clinical issues and future perspectives with regard to gastric non-balloon methods treating obesity.

Keywords

References

  1. Bray GA, Fruhbeck G, Ryan DH, Wilding JP. Management of obesity. Lancet 2016;387:1947-1956. https://doi.org/10.1016/S0140-6736(16)00271-3
  2. Marinos G, Eliades C, Raman Muthusamy V, Greenway F. Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study. Surg Obes Relat Dis 2014;10:929-934. https://doi.org/10.1016/j.soard.2014.03.005
  3. Sampath K, Rothstein RI. Selected endoscopic gastric devices for obesity. Gastrointest Endosc Clin N Am 2017;27:267-275. https://doi.org/10.1016/j.giec.2017.01.005
  4. Kushner RF. Weight loss strategies for treatment of obesity. Prog Cardiovasc Dis 2014;56:465-472. https://doi.org/10.1016/j.pcad.2013.09.005
  5. Telem DA, Talamini M, Shroyer AL, et al. Long-term mortality rates (>8-year) improve as compared to the general and obese population following bariatric surgery. Surg Endosc 2015;29:529-536. https://doi.org/10.1007/s00464-014-3714-4
  6. Bennett MC, Badillo R, Sullivan S. Endoscopic management. Gastroenterol Clin North Am 2016;45:673-688. https://doi.org/10.1016/j.gtc.2016.07.005
  7. Sullivan S, Edmundowicz SA, Thompson CC. Endoscopic bariatric and metabolic therapies: new and emerging technologies. Gastroenterology 2017;152:1791-1801. https://doi.org/10.1053/j.gastro.2017.01.044
  8. Verlaan T, de Jong K, de la Mar-Ploem ED, Veldhuyzen EA, Mathus-Vliegen EM, Fockens P. Trans-oral endoscopic restrictive implant system: endoscopic treatment of obesity? Surg Obes Relat Dis 2016;12:1711-1718. https://doi.org/10.1016/j.soard.2016.02.027
  9. Verlaan T, Paulus GF, Mathus-Vliegen EM, et al. Endoscopic gastric volume reduction with a novel articulating plication device is safe and effective in the treatment of obesity (with video). Gastrointest Endosc 2015;81:312-320. https://doi.org/10.1016/j.gie.2014.06.017
  10. Sartoretto A, Sui Z, Hill C, et al. Endoscopic sleeve gastroplasty (ESG) is a reproducible and effective endoscopic bariatric therapy suitable for widespread clinical adoption: a large, international multicenter study. Obes Surg 2018;28:1812-1821. https://doi.org/10.1007/s11695-018-3135-x
  11. Lopez-Nava G, Sharaiha RZ, Vargas EJ, et al. Endoscopic sleeve gastroplasty for obesity: a multicenter study of 248 patients with 24 months follow-up. Obes Surg 2017;27:2649-2655. https://doi.org/10.1007/s11695-017-2693-7
  12. Familiari P, Costamagna G, Blero D, et al. Transoral gastroplasty for morbid obesity: a multicenter trial with a 1-year outcome. Gastrointest Endosc 2011;74:1248-1258. https://doi.org/10.1016/j.gie.2011.08.046
  13. Moreno C, Closset J, Dugardeyn S, et al. Transoral gastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: results of the second human pilot study. Endoscopy 2008;40:406-413. https://doi.org/10.1055/s-2007-995748
  14. Kumar N. Endoscopic therapy for weight loss: gastroplasty, duodenal sleeves, intragastric balloons, and aspiration. World J Gastrointest Endosc 2015;7:847-859. https://doi.org/10.4253/wjge.v7.i9.847
  15. Hill C, Khashab MA, Kalloo AN, Kumbhari V. Endoluminal weight loss and metabolic therapies: current and future techniques. Ann N Y Acad Sci 2018;1411:36-52. https://doi.org/10.1111/nyas.13441
  16. Miller K, Turro R, Greve JW, Bakker CM, Buchwald JN, Espinos JC. MILEPOST multicenter randomized controlled trial: 12-month weight loss and satiety outcomes after pose (SM) vs. medical therapy. Obes Surg 2017;27:310-322. https://doi.org/10.1007/s11695-016-2295-9
  17. Lopez-Nava G, Bautista-Castano I, Jimenez A, de Grado T, Fernandez-Corbelle JP. The primary obesity surgery endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes. Surg Obes Relat Dis 2015;11:861-865. https://doi.org/10.1016/j.soard.2014.09.026

Cited by

  1. Biomaterials in Gastroenterology: A Critical Overview vol.55, pp.11, 2019, https://doi.org/10.3390/medicina55110734